시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세포치료용 배지 시장 : 제품 유형별, 세포치료 유형별, 사업 규모별, 최종사용자 유형별, 주요 지역별 : 업계 동향과 세계 예측(-2035년)
Cell Therapy Media Market by Type of Product, Type of Cell Therapy, Scale of Operation, Type of End User and Key Geographical Regions : Industry Trends and Global Forecasts, Till 2035
상품코드 : 1616884
리서치사 : Roots Analysis
발행일 : 2024년 12월
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,799 ￦ 6,810,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,999 ￦ 9,932,000
PDF (One-Location Site License) help
PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,599 ￦ 15,041,000
PDF (Department License) help
PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 17,999 ￦ 25,542,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 세포치료용 배지 시장 규모는 2035년까지의 예측 기간 중 12%의 CAGR로 확대하며, 현재 11억 달러에서 2035년까지 44억 달러로 성장할 것으로 예측됩니다.

종양성 질환, 희귀질환, 만성질환 치료에서 FDA 승인을 받은 세포치료제의 수많은 발전과 입증된 성공에 힘입어, 이 치료법은 헬스케어 업계에서 큰 주목을 받고 있으며, 2019년 이후 1,000건 이상의 세포치료제 관련 임상시험이 시작되었습니다. 시작되었습니다는 점은 주목할 만합니다. 또한 35개 이상의 세포치료제와 유전자치료제가 다양한 지역에서 상용화되고 있습니다. 최근 승인된 세포치료제 중 주목할 만한 사례로는 Breyanzi(R), Carvykti(TM), Abecma(R) 등이 있습니다.

최근 수년간 세포치료제 생산에 대한 규제가 강화되고 있습니다. 세포치료제 소모품 생산과 관련된 규제 문제를 해결하기 위해 세포치료제 개발자의 90% 이상이 배양배지, 키트, 시약, 세포외 매트릭스를 고품질의 원료를 제공하는 데 필요한 전문성을 갖춘 공급업체에 아웃소싱하는 것을 선택하고 있습니다. 현재 80개 이상의 업체가 450개 이상의 연구 및 치료용 원료를 공급하고 있습니다. 또한 T세포, 줄기세포, 수지상세포, NK세포 등 다양한 인간 세포에 사용하기 위한 소모품을 생산할 수 있는 GMP 인증 시설을 보유하고 있다고 주장하는 업체도 있습니다.

세포치료의 환경이 계속 진화하는 가운데, 업계내 기술 혁신과 협력이 급증하면서 환자 치료를 변화시키고 재생의료의 지평을 넓힐 수 있는 새로운 치료 옵션의 길이 열릴 것으로 예상됩니다.

세계의 세포치료용 배지 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 세포치료 유형별, 사업 규모별, 최종사용자 유형별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 서문

제2장 개요

제3장 서론

제4장 시장 구도

제5장 기업 경쟁력 분석

제6장 주요 업계의 브랜드 포지셔닝

제7장 기업 개요

제8장 최근 동향과 구상

제9장 세포치료 소모품 프로바이더의 적절한 파트너 분석

제10장 루트 분석 가격 전략

제11장 수요 분석

제12장 시장 예측과 기회 분석

제13장 향후 동향과 향후 성장 기회

제14장 결론

제15장 인터뷰 기록

제16장 부록 I : 표 형식 데이터

제17장 부록 II : 기업 및 조직 리스트

KSA
영문 목차

영문목차

CELL THERAPY MEDIA MARKET: OVERVIEW

As per Roots Analysis, the global cell therapy media market is estimated to grow from USD 1.1 billion in the current year to USD 4.4 billion by 2035, at a CAGR of ~12% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Product

Type of Cell Therapy

Scale of Operation

Type of End User

Key Geographical Regions

CELL THERAPY MEDIA MARKET: GROWTH AND TRENDS

Driven by numerous advancements and the proven success of FDA approved cell therapies for the treatment of oncological disorders, rare diseases, and chronic diseases, this therapeutic modality has garnered considerable attention of players engaged in the healthcare industry. It is worth highlighting that, since 2019, more than 1,000 clinical trials focused on cell therapies have been initiated. Additionally, over 35 cell and gene therapies have been commercialized, across various geographical locations. Notable examples of recently approved cell therapies include Breyanzi(R), Carvykti(TM) and Abecma(R).

In recent years, regulatory stringency has increased for the production of cell therapy. In order to address the regulatory challenges linked to the production of cell therapy consumables, over 90% of cell therapy developers choose to outsource culture media, kits, reagents and extracellular matrices to suppliers who possess the necessary expertise to deliver high-quality raw materials. At present, more than 80 players are offering more than 450 research and / or therapeutic grade raw materials. In addition, some companies claim to have GMP certified facilities for the production of consumables, which are intended to be used for a range of human cells, including T-cells, stem cells, dendritic cells and NK cells.

As the landscape of cell therapy continues to evolve, we anticipate a surge in innovation and collaboration within the industry, paving the way for new therapeutic options that could transform patient care and expand the horizons of regenerative medicine.

CELL THERAPY MEDIA MARKET: KEY INSIGHTS

The report delves into the current state of the cell therapy media market and identifies potential growth opportunities within the industry. Some key findings from the report include:

1. Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes.

2. The market features the presence of over 80 firms across the globe; the majority of these stakeholders are emerging players based in North America.

3. A larger proportion of the kits available in the cell therapy domain comprises different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions.

4. Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml.

5. Predominantly, the cell therapy reagents are intended to be used at the discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation.

6. The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation.

7. In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios.

8. Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities.

9. We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings.

10. Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies.

11. Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process.

12. In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy consumables; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies.

13. A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy consumables market at an annualized rate of 12%.

CELL THERAPY MEDIA MARKET: KEY SEGMENTS

Extracellular Matrices is the Fastest Growing Segment in the Cell Therapy Media Market

Based on the type of product, the market is segmented into culture media, kits, cell culture reagents and extracellular matrices. It is worth highlighting that majority of the current cell therapy media market is captured by culture media.

T-Cell Therapy is Likely to Dominate the Cell Therapy Media Market During the Forecast Period

Based on the type of cell therapy, the market is segmented into T-Cell therapy, stem cell therapy, dendritic cell therapy and NK cell therapy. It is worth highlighting that the cell therapy consumables market for NK cell therapies is likely to grow at a relatively higher CAGR, during the forecast period. This can be attributed to the fact that currently, more than 75 NK cell therapy focused clinical studies are being evaluated for a myriad of disease indications. In the coming years, this number is anticipated to increase further, and this is likely to boost the market opportunity for such therapies.

By Scale of Operation, Commercial Scale is Likely to Dominate the Cell Therapy Media Market During the Forecast Period

Based on the scale of operation, the market is segmented into clinical and commercial scales. It is worth highlighting that the commercial scale cell therapy media market is likely to drive the market in the near future.

Industry Players Segment Accounts for the Largest Share of the Cell Therapy Media Market

Based on the type of end user, the market is segmented into industry and non-industry. It is worth highlighting that the cell therapy media market for industry players is likely to drive the market in the near future. This can be attributed to the fact that the industry players contribute significantly to the overall commercial market as majority of the approved therapies have been developed by such players.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. It is worth highlighting that, over the years, the market in Latin America is expected to grow at a higher CAGR.

Example Players in the Cell Therapy Media Market

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

CELL THERAPY MEDIA MARKET: RESEARCH COVERAGE

KEY QUESTIONS ANSWERED IN THIS REPORT

REASONS TO BUY THIS REPORT

ADDITIONAL BENEFITS

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

5. COMPANY COMPETITIVENESS ANALYSIS

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS

7. COMPANY PROFILES

8. RECENT DEVELOPMENTS AND INITIATIVES

9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS

10. ROOTS ANALYSIS PRICING STRATEGY

11. DEMAND ANALYSIS

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES

14. CONCLUDING REMARKS

15. INTERVIEW TRANSCRIPTS

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기